Home ›
Organizations ›
RARE CANCER RESEARCH FOUNDATION
RARE CANCER RESEARCH FOUNDATION
NC · Medical Research · EIN 463405526
8
Executives Disclosed
$1.8M
Annual Revenue
$3.1M
Total Assets
1.2:1
Internal Pay Ratio
RARE CANCER RESEARCH FOUNDATION has 8 executives with disclosed compensation. The highest-paid executive, Marshall Thompson (PRESIDENT), received peak total compensation of $194,903. The sector average for Medical Research executives is $311K.
Top Executive Compensation Over Time
Executive Compensation
| Name | Title | Peak Comp. | Latest Comp. | Years | vs. Household |
|---|---|---|---|---|---|
| Marshall Thompson | PRESIDENT | $195K | $195K | 2023–2024 | 2.6x |
| Robin Kageyama | DIR DATA PLA | $168K | $168K | 2024–2024 | 2.2x |
| Amber Smith | BIOBANK MANA | $150K | $150K | 2023–2024 | 2x |
| Susan Horrell | DIR STRATEGI | $145K | $0 | 2024–2024 | 1.9x |
| Kathryn Kay Coleman | PROD ENGINEE | $136K | $0 | 2024–2024 | 1.8x |
| Barbara Van Hare | PRES. OF PAT | $127K | $0 | 2022–2024 | 1.7x |
| Benjamin David Kamphaus | TECHNICAL FE | $107K | $0 | 2024–2024 | 1.4x |
| Hana Littleford | CLINICAL DAT | $102K | $0 | 2024–2024 | 1.4x |
Annual Summary
| Year | Executives | Avg. Comp. | Highest Comp. | Total Payroll |
|---|---|---|---|---|
| 2022 | 1 | $0 | $0 | $0 |
| 2023 | 3 | $194K | $194K | $194K |
| 2024 | 8 | $171K | $195K | $513K |
Email Alerts
Get notified about RARE CANCER RESEARCH FOUNDATION
Get an email when a new IRS Form 990 filing is posted that includes this organization. We send a confirmation link first - we don't add you to any other list.